Tag: Cancer
-
Promising Strategy for Treating Rare Forms of Leukemia Discovered
Northwestern Medicine scientists identified a drug that stops the reproduction of tumor cells in models of primary myelofibrosis and acute myeloid leukemia, a finding that has led to new clinical studies in the Lurie Cancer Center.
-
Examining Kinase Inhibitors to Treat Chronic Myeloid Leukemia
Francis Giles, MD, chief of Hematology/Oncology in the Department of Medicine, led a clinical study to test the efficacy and safety of a kinase inhibitor for the treatment of chronic myeloid leukemia.
-
New Player in Lung Cancer Progression Discovered
Northwestern Medicine scientists have shown for the first time that the Myosin 9b gene is correlated with lung cancer tumor formation and metastasis.
-
$17.4 Million Grant to Tackle Cancer in Chicago’s Lower-Income, Minority Neighborhoods
A new grant from the National Cancer Institute will help three Chicago universities work together with many of the city’s underserved communities to foster impactful cancer research, education, training and outreach.
-
Coffee Associated With Colon Cancer Survival
A recent study shows that patients treated for colon cancer who regularly drank caffeinated coffee had lower rates of cancer recurrence and mortality.
-
Implant Detects Spreading Cancer Cells Early
Northwestern Medicine scientists helped develop an implantable device that detects early breast cancer metastatic cells, a method that may enable physicians to identify cancer spreading in patients while treatments are still viable.
-
Clinical Trial Compares Lymphoma Regimens
A new study co-authored by a Northwestern Medicine scientist found no significant difference between two popular therapy regimens in patients with a subset of Hodgkin lymphoma.
-
Targeting an Ion Channel to Treat Common Pediatric Brain Tumor
A study co-authored by Northwestern Medicine scientist Rintaro Hashizume, MD, PhD, identified the EAG2 potassium channel as a target for treating medulloblastoma.
-
Grant Will Explore New Treatments for Acute Myeloid Leukemia
A multi-center team of scientists have received funding from the National Cancer Institute to develop compounds that may lead to an entirely new treatment for Acute Myeloid Leukemia (AML). The grant, which will provide $1.58 million over three years, will support medicinal chemistry, molecular modeling, and biological testing to optimize small molecule CXCR4-receptor antagonists and…
-
Using Nanotechnology to Fight Cancer
Northwestern University has received a five-year, $11.7 million grant from the National Cancer Institute to use nanotechnology to develop next-generation cancer treatments.
